549 results
Page 4 of 28
424B5
jjyujiz9xsbfzgij9wta
12 May 22
Prospectus supplement for primary offering
8:30am
S-8
EX-23.1
qusxsr qdzod
18 Jan 22
Registration of securities for employees
5:12pm
S-8
tcb8i9
18 Jan 22
Registration of securities for employees
5:12pm
S-8
EX-5.1
xecyy 5x3fxe0avat
18 Jan 22
Registration of securities for employees
5:12pm
8-K
EX-10.1
fpzcka6 fck871hyqvoq
10 Jan 22
Departure of Directors or Certain Officers
4:28pm
424B3
ulvi2kz
27 Dec 21
Prospectus supplement
5:01pm
8-K
EX-10.1
oe5qoietu0wgx xx4e9w
24 Nov 21
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma’s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
8:20am
8-K
EX-10.2
ent js85p286642xh7y
24 Nov 21
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma’s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
8:20am
8-K
EX-10.1
v4dkv 5rvgym29mya
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
EX-4.1
ehcea5ax
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
4m6toq szs6xv2rk
2 Sep 21
Seelos Therapeutics Announces Senior Management Appointments
4:01pm